🇺🇸 FDA
Pipeline program

Pelareorep

REO 029

Phase 2 small_molecule active

Quick answer

Pelareorep for Anal Cancer Metastatic is a Phase 2 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ONCOLYTICS BIOTECH INC
Indication
Anal Cancer Metastatic
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials